Giuliana Grossi

“Our study suggests that narrowly focusing on hospital volumes and tying that to insurance reimbursement might mask complexities and trade-offs in achieving the goal of optimizing patient outcomes and experiences,” lead co-author Lindsay Sabik, PhD, says.

In this interview, Catherine Nester, RN explains the importance of entering phase 2 of the whole genome sequencing newborn screening program.

The new rule is poised to foster safety, equity, and reduce preventable harm within the hospital setting in historically underserved communities.

BeginNGS aims to enable the prompt identification of potential genetic disease with its newborn screening program.

The BeginNGS program added 23 new founding members to the consortium and expanded to include 31 additional genetic disorders in its second phase screening, totaling 419 treatable genetic disorders.

Even after adjustments, the underlying trends in disparities persisted, underscoring the significance of survival disparities among second primary cancer survivors.

Among 2.5 million adults with opioid use disorder (OUD), only 36% received any substance use treatment, and only 22% received medications for OUD in a recent study.

The data provide promising results, yielding a smoking abstinence rate of 26.4% in the intervention group at 18 months.

"Our research is unique in its attempt to describe a high-need, high-cost patient population who might benefit from increased monitoring or intervention,"Ann Cameron, PhD, says.

An immune-mediated relationship between the brain and skin has been hypothesized in previous studies about psoriasis.